Court Ruling On Pfizer Price Hikes Could Delay Other Investigations, Warns UK Competition Authority

Ongoing Investigations into drug price increases could be at risk following a tribunal ruling in the UK phenytoin sodium case, according to the Competition and Markets Authority, which is considering an appeal against the judgment.

Gavel_1200x675
Pfizer Wins Appeal Against Competition Authority Price Increases Decision • Source: Shutterstock

The UK’s Competition Appeal Tribunal has ruled against a decision by the Competition and Markets Authority that Pfizer and Flynn Pharma breached competition law by charging excessive prices for phenytoin sodium capsules for epilepsy. Disappointed with the judgement, the CMA has warned that active investigations into alleged price gouging may be “severely delayed” as a result.

But Pfizer which appealed against the CMA’s 2016 ruling and record fines, has welcomed the tribunal’s findings. “We are pleased...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography